Market Overview

According to various statistics and available data, the global Oncology drug market size was valued at $135,494.17 million in 2021, and now it is projected to reach $274,400.63 million by 2030, registering a CAGR of 7.5% from 2021 to 2030.

The growth of the Oncology/cancer drugs market is driven by the drastic increase in prevalence of cancer disease including all types of cancer conditions.

Rise in incidence of various cancer conditions, increase in popularity of advanced therapies (biological and targeted drug therapies), and surge in geriatric population worldwide.

In addition, rise in cancer awareness, early screening of the cancer also contributes toward growth of the oncology drugs market. However, high cost involved in new drug development coupled with threat of failure & adverse effects associated with cancer drugs therapies pose to restrain the growth of the oncology/cancer drugs market.

Conversely, high potential of emerging economies and higher number of potential drugs in the pipeline are expected to offer lucrative opportunities during the forecast period.

The end users which Kremedine wants to reach out to are all the cancer patients and Kremedine wants to make sure that it is able to help each and every segment in whatever way it can and also wants to be available to all the cancer patients.